AcroBiosystems leans on overseas sales in renewed Hong Kong listing bid
The company leads the field for recombinant proteins among its domestic peers, but overseas companies dominate the international market Key Takeaways: AcroBiosystems has applied to list in Hong Kong, reporting…
Recent Articles
RELATED ARTICLES
-
Looking for overseas growth, Aier Eye seeks Hong Kong listing
300015.SHE -
Newborn Town leans on better monetization as user growth slows
9911.HK
- ESWIN Computing powers up its RISC-V growth story for Hong Kong investors
- Unsated by Hong Kong listing, Knowledge Atlas seeks more funds in Shanghai
-
Shantui Construction bulldozes its way towards Hong Kong listing
000680.SHE
- Fosun tries again with new Club Med Hong Kong IPO bid
- Avatr parks its NEV listing in Hong Kong, complete with losses and state ownership
